Literature DB >> 23625283

Analysis of the genome-wide DNA methylation profile of side population cells in hepatocellular carcinoma.

Jing-Ming Zhai1, Xiao-Yu Yin, Xun Hou, Xiao-Yi Hao, Jian-Peng Cai, Li-Jian Liang, Long-Juan Zhang.   

Abstract

BACKGROUND: DNA methylation plays an important role in maintaining pluripotency and regulating the differentiation of stem cells, but the DNA methylation profile of stem cells in hepatocellular carcinoma (HCC) remains unclear. AIMS: To investigate the genome-wide DNA methylation profile of side population (SP) cells of HCC, a special subpopulation of cells enriched with cancer stem cells, by DNA methylation microarray analysis and to analyze the functions and signal pathways of the aberrantly methylated genes in SP cells.
METHODS: Side population cells were isolated from HCC cell lines Huh7 and PLC/PRF/5 using flow cytometry, and the tumorigenicity of these SP cells was assessed in NOD/SCID mice. The genome-wide DNA methylation status of SP cells and non-SP (NSP) cells was detected and compared by DNA methylation microarray analysis. Genes with differential methylation between SP and NSP cells were further analyzed for their functions and roles in related signaling pathways.
RESULTS: Subcutaneous inoculation of 1 × 10(3) SP cells yielded tumors in 60 % NOD/SCID mice, whereas no tumor was developed after the inoculation of 1 × 10(6) NSP cells. Genome-wide DNA methylation microarray analysis showed that 72 and 181 genes were hypermethylated and hypomethylated, respectively, in both Huh7 and PLC/PRF/5 SP cells as compared with their corresponding NSP cells. Analyses of signaling pathways revealed that hypermethylated and hypomethylated genes were related to four and eight pathways, respectively.
CONCLUSIONS: Hepatocellular carcinoma SP cells possessed a differential DNA methylation status compared with NSP cells, and the differentially methylated genes in SP cells were involved in 12 signaling pathways. Our results provide valuable clues for further investigations in elucidating the importance of epigenetic regulation in sustaining HCC SP cells and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23625283     DOI: 10.1007/s10620-013-2663-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer.

Authors:  Yuanhong Xu; Zhe Liu; Kejian Guo
Journal:  Mol Cell Biochem       Date:  2011-12-06       Impact factor: 3.396

2.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

3.  The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene.

Authors:  Cyril Duriez; Nicole Falette; Carole Audoynaud; Caroline Moyret-Lalle; Karim Bensaad; Stéphanie Courtois; Qing Wang; Thierry Soussi; Alain Puisieux
Journal:  Gene       Date:  2002-01-09       Impact factor: 3.688

Review 4.  The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?

Authors:  F Tirone
Journal:  J Cell Physiol       Date:  2001-05       Impact factor: 6.384

5.  CD13 is a therapeutic target in human liver cancer stem cells.

Authors:  Naotsugu Haraguchi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Masahisa Ohkuma; Ho Min Kim; Hirofumi Akita; Daisuke Takiuchi; Hisanori Hatano; Hiroaki Nagano; Graham F Barnard; Yuichiro Doki; Masaki Mori
Journal:  J Clin Invest       Date:  2010-08-09       Impact factor: 14.808

6.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Authors:  Stephanie Ma; Kwok-Wah Chan; Liang Hu; Terence Kin-Wah Lee; Jana Yim-Hung Wo; Irene Oi-Lin Ng; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2007-04-15       Impact factor: 22.682

7.  Gadd45b and Gadd45g are important for anti-tumor immune responses.

Authors:  Songguang Ju; Yibei Zhu; Lin Liu; Shao Dai; Changyou Li; Elizabeth Chen; Yukai He; Xueguang Zhang; Binfeng Lu
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

8.  TIS21/(BTG2) negatively regulates estradiol-stimulated expansion of hematopoietic stem cells by derepressing Akt phosphorylation and inhibiting mTOR signal transduction.

Authors:  Bong Cho Kim; Min Sook Ryu; S Paul Oh; In Kyoung Lim
Journal:  Stem Cells       Date:  2008-06-12       Impact factor: 6.277

Review 9.  Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.

Authors:  Tetsuhiro Chiba; Akihide Kamiya; Osamu Yokosuka; Atsushi Iwama
Journal:  Cancer Lett       Date:  2009-05-22       Impact factor: 8.679

10.  Gene expression profiling of liver cancer stem cells by RNA-sequencing.

Authors:  David W Y Ho; Zhen Fan Yang; Kang Yi; Chi Tat Lam; Michael N P Ng; Wan Ching Yu; Joyce Lau; Timothy Wan; Xiaoqi Wang; Zhixiang Yan; Hang Liu; Yong Zhang; Sheung Tat Fan
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

View more
  10 in total

1.  BTG2 Is Down-Regulated and Inhibits Cancer Stem Cell-Like Features of Side Population Cells in Hepatocellular Carcinoma.

Authors:  Chen-Song Huang; Jing-Ming Zhai; Xiao-Xu Zhu; Jian-Peng Cai; Wei Chen; Jian-Hui Li; Xiao-Yu Yin
Journal:  Dig Dis Sci       Date:  2017-11-02       Impact factor: 3.199

2.  Expression of SOX2 in oral squamous cell carcinoma and the association with lymph node metastasis.

Authors:  Zhen-Hu Ren; Chen-Ping Zhang; Tong Ji
Journal:  Oncol Lett       Date:  2016-02-09       Impact factor: 2.967

Review 3.  DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.

Authors:  Sumadi Lukman Anwar; Ulrich Lehmann
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 4.  Cellular reprogramming and hepatocellular carcinoma development.

Authors:  Yun-Wen Zheng; Yun-Zhong Nie; Hideki Taniguchi
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

Review 5.  New insights on the role of epigenetic alterations in hepatocellular carcinoma.

Authors:  Maddalena Frau; Claudio F Feo; Francesco Feo; Rosa M Pascale
Journal:  J Hepatocell Carcinoma       Date:  2014-06-12

6.  Epigenetic Optical Mapping of 5-Hydroxymethylcytosine in Nanochannel Arrays.

Authors:  Tslil Gabrieli; Hila Sharim; Gil Nifker; Jonathan Jeffet; Tamar Shahal; Rani Arielly; Michal Levi-Sakin; Lily Hoch; Nissim Arbib; Yael Michaeli; Yuval Ebenstein
Journal:  ACS Nano       Date:  2018-06-25       Impact factor: 15.881

7.  Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2.

Authors:  Zheng-Yuan Xie; Mao-Sheng Liu; Cong Zhang; Peng-Cheng Cai; Zhi-Hua Xiao; Fen-Fen Wang
Journal:  Biosci Rep       Date:  2018-11-09       Impact factor: 3.840

8.  Genome-Wide DNA Methylation Pattern of Cancer Stem Cells in Esophageal Cancer.

Authors:  Xiying Yu; Ying Teng; Xingran Jiang; Hui Yuan; Wei Jiang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

9.  Natural compounds' activity against cancer stem-like or fast-cycling melanoma cells.

Authors:  Malgorzata Sztiller-Sikorska; Kamila Koprowska; Kinga Majchrzak; Mariusz Hartman; Malgorzata Czyz
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

Review 10.  Replication-dependent histone isoforms: a new source of complexity in chromatin structure and function.

Authors:  Rajbir Singh; Emily Bassett; Arnab Chakravarti; Mark R Parthun
Journal:  Nucleic Acids Res       Date:  2018-09-28       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.